Hepatitis C Journal Articles

• Genetic Factors in Sofosbuvir Treatment for Chronic HCV Are there patient-specific genetic factors that might help predict HCV patients likely to fail sofosbuvir treatment?
  Liver International, May 23, 2022
• Incidence and Mortality of HBV and HCV, Cirrhosis and HCC This article provides an update on the global incidence and mortality rates for these liver diseases. How have they changed in recent years?
  Journal of Viral Hepatitis, May 23, 2022
• Comorbidities and Co-Medications Among People With HIV How prevalent are comorbidities and the use of non-ART co-medications among people living with HIV?
  HIV Medicine, May 19, 2022
• Medicaid Restriction Removal Increased HCV Treatment Rates Access to treatment improved after Medicaid-imposed restrictions were removed, but more policy changes are needed to address remaining disparities.
  Journal of Viral Hepatitis, May 16, 2022
• Adherence to the DASH Diet and NAFLD Is the DASH (Dietary Approaches to Stop Hypertension) diet effective at lowering risk of NAFLD?
  Liver International, May 09, 2022
• HCV-Related Depression, Anxiety, and Cognitive Improvements Chronic HCV patients may realize neuropsychiatric and cognitive improvements after achieving sustained virological response with direct-acting antiviral agents.
  Journal of Viral Hepatitis, May 09, 2022
• Overt HE in Cirrhotic Patients With Acute Decompensation This study aimed to determine whether the occurrence of overt hepatic encephalopathy is an independent risk factor for de novo infection in patients with cirrhosis and acute decompensation.
  Alimentary Pharmacology & Therapeutics, April 27, 2022
• Incidence of HCV Related HCC in the Era of IFN-free Therapies This study examined trends over time of HCV-associated hepatocellular carcinoma. How has incidence changed since the introduction of IFN-free therapies?
  Liver International, April 25, 2022
• HCV Cascade of Care Among People Living With HIV This study characterized the HCV care cascade among people living with HIV in New South Wales, comparing HCV testing and treatment uptake between pre- and post-introduction of DAAs in Australia.
  Journal of Viral Hepatitis, April 25, 2022
• Integrating HCV Screening of Baby Boomers at a Hospital ED This paper details the implementation of an opt-in HCV screening program for baby boomers presenting to a community hospital emergency department.
  Journal of Viral Hepatitis, April 18, 2022
• Chronic Hepatitis D--What Is Changing? Several new approaches to hepatitis D virus therapy have been explored in recent years. Review these advances and novel therapeutic options for HDV in this paper.
  Journal of Viral Hepatitis, April 04, 2022
• Hepatitis D Hospitalizations in the U.S.: 2010-2018 A new study provides insight into the hospitalization rates of hepatitis D in the U.S. and the various characteristics of these patients.
  Journal of Viral Hepatitis, March 31, 2022
• Lower Incidence of HIV-1 Blips During INSTI-Based ART A new study observes a lower number of viral blips during INSTI-based treatment compared with other ART regimens.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 30, 2022
• Liver-related and Extrahepatic Events in Patients With NAFLD This study evaluated the probability of developing liver-related events and extrahepatic events, considered as competing risks, in patients with NAFLD, stratified by fibrosis stage.
  Alimentary Pharmacology & Therapeutics, March 24, 2022
• Overseas Treatment of Latent TB in US-Bound Immigrants Could TB testing and treatment of immigrants before arrival in the U.S. help prevent the importation of the disease?
  Emerging Infectious Diseases, March 22, 2022
• The Impact of Waves of COVID-19 on HBV and HCV Testing In what ways were HBV and HCV testing impacted during the first three waves of the COVID-19 pandemic? A new study examines the trends.
  Journal of Viral Hepatitis, March 17, 2022
• Hepatocellular Carcinoma in Noncirrhotic and Cirrhotic livers What are the clinicopathologic differences between hepatocellular carcinoma arising in noncirrhotic and cirrhotic livers?
  American Journal of Clinical Pathology, March 09, 2022
• E-Nose vs Quadrupole Mass Spectrometry for Identifying HCV This study suggests that E-Nose technology can be an economical, easy-to-use, portable and non-invasive tool for screening and early diagnosis of HCV infection.
  Journal of Viral Hepatitis, March 07, 2022
• HCV Care: Targeting People With Diabetes, Hazardous Alcohol Use What factors drive late presentation for HCV care? This study highlights the need to identify and target people with diabetes and/or past or current hazardous alcohol use for HCV screening.
  Liver International, February 28, 2022
• Role of Gut Microbiota in HBV Disease Progression and Treatment This review aims to clarify our understanding of the pathophysiology of gut microbiota and their relationship with liver injury in chronic hepatitis B. How might this inform future therapeutics?
  Journal of Viral Hepatitis, February 21, 2022